References
- Abe K., Kusano K., Nakamura T., Narita T., Taki T., Yuzuriha T., Horie T., Ohmori S., Kanakubo Y. Dual effect of triazolodiazepine derivative, E-6123 on monooxygenase of dogs. Proceedings of the Third International ISSX Meeting. 1991, 80
- Bast A., Savenije-Chapel E. M., Krobe B. H. Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers. Xenobiotica 1984; 14: 399–408
- Daling Z., Tanaka E., Nakamura T., Horie T. The effect of E-5110, a novel non-steroidal anti-inflammatory drug, on trimethadione metabolism as an indicator of hepatic drug-oxidizing capacity in beagle dogs. Xenobiotica 1994; 24: 215–220
- Danhof M., De Boer A. G., De Groot-van Der Vis E., Breimer D. D. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment. Xenobiotica 1979; 9: 695–702
- Guengerich F. P., Wang P., Davidson N. K. Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dedecyl sulfate polyacrylamide gel electrophoresis. Biochemistry 1982; 21: 1698–1706
- Imai Y., Ito A., Sato R. Evidence for biochemically different type of vesicles in the hepatic microsomal function. Journal of Biochemistry 1966; 60: 447–428
- Kamataki T., Kitada M., Shigematsu H., Kitagawa H. The involvement of cytochrome P-448 and P-450 in NADH-dependent O-demethylation of p-nitroanisole in ratliver microsome. Japanese Journal of Pharmacology 1979; 29: 191–201
- Knodell R. G., Holtzman J. L., Crankshaw D. L., Steele N. M., Stanley L. N. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists. Gastroenterology 1982; 82: 84–88
- Laemmli U. K. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
- Lindstrom T., Whitaker G. W., Pioch R. P. Inhibition of microsomal biotransformation by a series of nitrogen and oxygen heterocyclic histamine H2-antagonists. Biochemical Pharmacology 1987; 36: 1669–1672
- Loft S. Metronidazole and antipyrine as probes for the study of foreign compound metabolism. Pharmacology and Toxicology 1990; 66(Suppl. VI)1–31
- Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
- Nakamura M., Tanaka E., Misawa S., Shimada T., Imaoka S., Funae Y. Trimethadione metabolism, a useful indicator for the assessment of hepatic drug-oxidizing capacity. Biochemical Pharmacology 1994; 47: 247–251
- Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsh reaction. Biochemical Journal 1953; 55: 416–421
- Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
- Tanaka E., Ishikawa A., Ono A., Okamura T., Misawa S. Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease. Journal of Pharmacobio-Dynamics 1987; 10: 499–502
- Tanaka E., Kinoshita H., Yoshida T., Kuroiwa Y. Determination of plasma trimethadione and its metabolite in carbon tetrachloride-intoxicated rat liver: a useful tool for estimation of hepatic drug-metabolizing capacity. Journal of Pharmacobio-Dynamics 1981; 4: 961–967
- Tanaka E., Misawa S. Improved method for the determination of trimethadione and its demethylated metabolite, dimethadione, in human serum by gas chromatography. Journal of Chromatography, Biomedical Applications 1992; 584: 267–269
- Teunissen M. W. E., Meerburg-van Der Torren J. E., Vermeulen N. P. E., Breimer D. D. Automated HPLC-determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4′-dihydroxyantipyrine. Journal of Chromatography, Biomedical Applications 1983; 278: 367–378
- Vesell E. S. The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clinical Pharmacology and Therapeutics 1979; 26: 275–286